Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

127.95 +0.41 (+0.32%)
Official Closing Price Updated: 4:10 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
A Look Into Abbott Laboratories Inc's Price Over Earnings
 
Via Benzinga
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call
Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the market reacted negatively, with shares declining over 4%. Management pointed to... 
Via StockStory
Topics Earnings
U.S. Job Growth Stalls at 0.1%: Echoes of 2009 as Economy Navigates Fragile Labor Market
The U.S. economy is currently grappling with a significant deceleration in job growth, with proprietary data from investment giant Vanguard revealing a meager 0.1% growth rate for seven of the first... 
Via MarketMinute
Topics Artificial Intelligence Economy Immigration
Abbott Laboratories' October Price Plunge Is a Signal to Buy
Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend. 
Via MarketBeat
Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength
Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion. 
Via Benzinga
These Analysts Revise Their Forecasts On Abbott Following Q3 Results
 
Via Benzinga
Earnings Season Fuels Market Optimism Amidst Economic Headwinds
As the Q3 2025 earnings season unfolds, corporate America is delivering a powerful narrative of resilience and growth, significantly influencing overall stock market movements. Despite a complex... 
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Investors should be able to count on these stocks to deliver steady and growing income over the long term. 
Via The Motley Fool
ABT Q3 Deep Dive: Q3 Results in Line with Expectations, Product Pipeline and Market Dynamics Shape Outlook
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30... 
Via StockStory
Topics World Trade
U.S. Stocks End Mixed Amidst Trade Tensions, Dovish Fed Hopes, and Robust Earnings
The U.S. stock market closed with a mixed performance recently, reflecting a complex and dynamic environment where investor sentiment is being pulled in multiple directions. As of October 15, 2025, a... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Why Abbott Laboratories (ABT) Stock Is Down Today
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not... 
Via StockStory
Gold Gains Over 1%; Abbott Shares Fall After Q3 Results
 
Via Benzinga
Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025
In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Wednesday's session: top gainers and losers in the S&P500 index
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows
Via The Motley Fool
Topics Regulatory Compliance
Bank Earnings Lift Wall Street, Gold Hits $4,200: What's Moving Markets Wednesday?
Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectations for further Federal Reserve rate cuts — keeping trade concerns... 
Via Benzinga
Topics Economy
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session. 
Via Chartmill
1 No-Brainer Dividend Stock to Buy and Hold Forever
This is about as safe as a dividend can be. 
Via The Motley Fool
Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations
Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices. 
Via Benzinga
Topics Earnings
Abbott Labs Skids On Mixed Third-Quarter Report, But One Segment Shined
Notably, the company reaffirmed its sales guidance and the midpoint of its earnings outlook. 
Via Investor's Business Daily
What's going on in today's pre-market session: S&P500 movers
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Abbott Laboratories (NYSE:ABT) Trims 2025 Outlook After Q3 Earnings
Abbott Labs Q3 2025 results met EPS views, but trimmed full-year guidance. Sales grew 6.9% as the healthcare giant navigates a complex market. 
Via Chartmill
Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30... 
Via StockStory
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'
U.S. stock futures advanced on Wednesday following Tuesday’s mixed close. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Stocks
Earnings Scheduled For October 15, 2025
 
Via Benzinga
Dow Jumps Over 200 Points Following Strong Bank Earnings: Investor Fear Eases Slightly, But Greed Index Remains In 'Fear' Zone
Dow Jones gains, but trade tensions limit enthusiasm. Wells Fargo, Citi, JPMorgan, and Goldman Sachs beat expectations. 
Via Benzinga
Topics Stocks World Trade
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Wednesday
US stock futures higher, BAC, PZZA, MS expected to report earnings, ASML reports better-than-expected bookings, ABT to report earnings. 
Via Benzinga
A Look Ahead: Abbott Laboratories's Earnings Forecast
 
Via Benzinga
Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.